LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

Home・Listă Acțiuni・Certara Inc

Certara Inc

Deschisă

SectorSănătate

4.67 0.86

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

4.44

Maxim

4.68

Indicatori cheie
By Trading Economics
Venit	-2.9M -8.8M
Vânzări	3.3M 107M
P/E Medie Sector	100.714 49.701
EPS	0.09
Marjă de profit	-8.196
Angajați	1,515
EBITDA	-8.9M 23M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+76.75% upside

Dividende
By Dow Jones
Următoarele câștiguri	5 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-89M 709M
Deschiderea anterioară	3.81
Închiderea anterioară	4.67

Sentimentul știrilor

By Acuity

55%

45%

286 / 345 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

11.27 / 12.79 Suport & Rezistență

Certara Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 mai 2026, 20:36 UTC

Achiziții, Fuziuni, Preluări

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19 mai 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19 mai 2026, 23:34 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19 mai 2026, 23:28 UTC

Market Talk

Câștiguri

Global Forex and Fixed Income Roundup: Market Talk

19 mai 2026, 23:28 UTC

Market Talk

Câștiguri

F&P Healthcare's Outlook Key for Investors -- Market Talk

19 mai 2026, 23:10 UTC

Market Talk

Global Equities Roundup: Market Talk

19 mai 2026, 23:10 UTC

Market Talk

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19 mai 2026, 22:02 UTC

Câștiguri

ZTO Express (Cayman): Di Xu to Resign From Board

19 mai 2026, 22:01 UTC

Câștiguri

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19 mai 2026, 22:01 UTC

Câștiguri

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19 mai 2026, 22:00 UTC

Câștiguri

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19 mai 2026, 21:37 UTC

Câștiguri

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19 mai 2026, 21:31 UTC

Achiziții, Fuziuni, Preluări

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19 mai 2026, 21:01 UTC

Câștiguri

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19 mai 2026, 20:58 UTC

Câștiguri

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19 mai 2026, 20:46 UTC

Acțiuni populare

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19 mai 2026, 20:43 UTC

Market Talk

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19 mai 2026, 20:34 UTC

Câștiguri

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19 mai 2026, 20:32 UTC

Câștiguri

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19 mai 2026, 20:32 UTC

Câștiguri

James Hardie Industries 4Q EPS 5c >JHX

19 mai 2026, 20:32 UTC

Câștiguri

James Hardie Industries 4Q Sales $1.4B >JHX

19 mai 2026, 20:21 UTC

Achiziții, Fuziuni, Preluări

Analog Devices to Buy Empower Semiconductor for $1.5B

19 mai 2026, 20:18 UTC

Market Talk

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19 mai 2026, 20:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 mai 2026, 20:13 UTC

Market Talk

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19 mai 2026, 20:03 UTC

Achiziții, Fuziuni, Preluări

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19 mai 2026, 20:03 UTC

Achiziții, Fuziuni, Preluări

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19 mai 2026, 20:02 UTC

Achiziții, Fuziuni, Preluări

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19 mai 2026, 20:02 UTC

Achiziții, Fuziuni, Preluări

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19 mai 2026, 19:23 UTC

Market Talk

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Comparație

Modificare preț

Certara Inc Așteptări

Obiectiv de preț

By TipRanks

76.75% sus

Prognoză pe 12 luni

Medie 8.06 USD 76.75%

Maxim 10 USD

Minim 6 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCertara Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 10 analiști care au acordat evaluări ale acțiunilor Certara Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

11.27 / 12.79Suport & Rezistență

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

286 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.